InvestorsHub Logo
Followers 4
Posts 309
Boards Moderated 0
Alias Born 07/09/2018

Re: None

Monday, 01/20/2020 11:31:48 AM

Monday, January 20, 2020 11:31:48 AM

Post# of 1032
New CEO is apparently trying to get his hands around the mess created out of a promising technology. However, some announcements in this press release don't easily fit together:

Facts
4Q revenues - slightly greater than $700K for 4Q 2019 (miniscule at this point)
4Q Expenses/cash burn - $9.4 M

2020 Revenue forecast - $7M - $9M (a broad range for a 12 month forecast)
2020 revenuie forecast is a very significant uptick from actual 4Q 2019 for a company that hasn't been able to date to generate appreciable revenue.

ECOR comments that "We have identified multiple large existing or near term revenue channels that we are actively pursuing on a more focused basis, while also working to further tap the commercial payer market and expand gammaCore's label into additional high-value indications" doesn't seem to add up to a concrete & different strategy than the prior stratgey. So what's the basis for the forecast big uptick in revenues? how is this strategy different than the previous strategy?
As a shareholder, I have hope that the new CEO can turn the ship around; I trust that management has more concrete plans.

ECOR inmplies that it has financial runway until early 2021; forecatsing profit & cash flow breakeven for late 2021. We must poresume that this pro forma is based on the 2020 revenue uptick forecasted.

I note that the website no longer lists JP as a memnber of the leadership team...a good step though belated in the estimates of many.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ECOR News